How to buy Biotron shares | A$0.098
Own Biotron shares in just a few minutes.
Biotron Limited is a biotechnology business based in Australia. Biotron shares (BIT) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.098 – a decrease of 6.67% over the previous week. Biotron has a trailing 12-month revenue of around $803,026.
How to buy shares in Biotron
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Biotron. Find the share by name or ticker symbol: BIT. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Biotron reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $0.098, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Biotron. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
How has coronavirus impacted Biotron's share price?
Since the stock market crash in March caused by coronavirus, Biotron's share price has had significant negative movement.
Its last market close was $0.098, which is 10.91% down on its pre-crash value of $0.11 and 48.48% up on the lowest point reached during the March crash when the shares fell as low as $0.066.
If you had bought $1,000 worth of Biotron shares at the start of February 2020, those shares would have been worth $755.56 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,088.89.
Biotron share priceUse our graph to track the performance of BIT stocks over time.
Biotron shares at a glance
|Latest market close||AUDA$0.098|
|52-week range||AUDA$0.05 - AUDA$0.185|
|50-day moving average||AUDA$0.1005|
|200-day moving average||AUDA$0.0968|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||AUDA$-0.003|
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
Important: Share trading carries risk of capital loss.
Compare share trading platforms
Is it a good time to buy Biotron stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Biotron price performance over time
|1 week (2020-09-11)||-6.67%|
|1 month (2020-08-18)||-2.00%|
|3 months (2020-06-18)||25.64%|
|6 months (2020-03-18)||10.11%|
|1 year (2019-09-18)||36.11%|
|2 years (2018-09-18)||444.44%|
|3 years (2017-09-18)||536.36%|
|5 years (2015-09-18)||13.29%|
|Gross profit TTM||$803,026|
|Return on assets TTM||-33.25%|
|Return on equity TTM||-57.62%|
|Market capitalisation||$68.8 million|
TTM: trailing 12 months
Biotron share dividends
We're not expecting Biotron to pay a dividend over the next 12 months.
Have Biotron's shares ever split?
Biotron's shares were split on 26 March 2006.
Biotron share price volatility
Over the last 12 months, Biotron's shares have ranged in value from as little as $0.05 up to $0.185. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Biotron's is -1.8837. This would suggest that Biotron's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Biotron has bucked the trend.
Biotron Limited, a biotechnology company, engages in the developing and commercializing novel small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including dengue, zika, influenza, ebola, and SARs. Biotron Limited was incorporated in 1999 and is based in North Ryde, Australia.
Frequently asked questions
Ask an Expert